Cash and Cash Equivalents, at Carrying Value of China SXT Pharmaceuticals, Inc. from 31 Mar 2016 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
China SXT Pharmaceuticals, Inc. quarterly Cash and Cash Equivalents, at Carrying Value in USD history and change rate from 31 Mar 2016 to 31 Mar 2025.
  • China SXT Pharmaceuticals, Inc. Cash and Cash Equivalents, at Carrying Value for the quarter ending 31 Mar 2025 was $18,099,019, a 50% increase year-over-year.
Source SEC data
View on sec.gov
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

China SXT Pharmaceuticals, Inc. Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $18,099,019 +$6,028,674 +50% 31 Mar 2025 20-F 31 Jul 2025 2025 FY
Q3 2024 $18,512,756 +$7,047,736 +61% 30 Sep 2024 6-K 28 Mar 2025 2025 Q2
Q1 2024 $12,070,345 -$5,298,133 -31% 31 Mar 2024 20-F 31 Jul 2025 2025 FY
Q3 2023 $11,465,020 +$8,483,986 +285% 30 Sep 2023 6-K 05 Apr 2024 2024 Q2
Q1 2023 $17,368,478 +$1,844,156 +12% 31 Mar 2023 20-F 13 Aug 2024 2024 FY
Q3 2022 $2,981,034 +$2,949,713 +9418% 30 Sep 2022 6-K 24 Feb 2023 2023 Q2
Q1 2022 $15,524,322 +$2,191,294 +16% 31 Mar 2022 6-K 24 Feb 2023 2023 Q2
Q3 2021 $31,321 -$10,322,153 -100% 30 Sep 2021 6-K 14 Jan 2022 2022 Q2
Q1 2021 $13,333,028 +$6,045,996 +83% 31 Mar 2021 6-K 14 Jan 2022 2022 Q2
Q3 2020 $10,353,474 +$2,106,405 +26% 30 Sep 2020 6-K 28 Jan 2021 2021 Q2
Q1 2020 $7,287,032 -$2,004,901 -22% 31 Mar 2020 20-F 13 Aug 2021 2021 FY
Q3 2019 $8,247,069 +$7,863,463 +2050% 30 Sep 2019 6-K/A 22 May 2020 2020 Q2
Q1 2019 $9,291,933 +$8,634,166 +1313% 31 Mar 2019 20-F 13 Aug 2021 2021 FY
Q3 2018 $383,606 30 Sep 2018 6-K/A 22 May 2020 2020 Q2
Q1 2018 $657,767 +$592,197 +903% 31 Mar 2018 20-F 13 Aug 2021 2021 FY
Q1 2017 $65,570 +$54,131 31 Mar 2017 20-F 31 Jul 2020 2020 FY
Q1 2016 $11,439* 31 Mar 2016 20-F 15 Aug 2019 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.